002688.SZ

Jinhe Biotechnology CO., LTD. [002688.SZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

002688.SZ Stock Summary

Top 10 Correlated ETFs

002688.SZ

Top 10 Correlated Stocks

002688.SZ

In the News

002688.SZ Financial details

Company Rating
-
Market Cap
2.96B
Income
83.05M
Revenue
2.06B
Book val./share
-
Cash/share
-
Dividend
0.1
Dividend %
2.13%
Employees
2.29K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2024
P/E
44.04
Forward P/E
-
PEG
-19.57
P/S
1.82
P/B
1.61
P/C
-
P/FCF
-13.74
Quick Ratio
0.64
Current Ratio
0.95
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.11
EPS next Y
-
EPS next Q
-
EPS this Y
7.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.42%
Revenue last 5Y
5.44%
Revenue Q/Q
6.37%
EPS Q/Q
-73.85%
-
-
-
-
SMA20
20%
SMA50
50%
SMA100
20%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
4%
ROC
0.03%
Gross Margin
31%
Oper. Margin
4%
Profit Margin
4%
Payout
170%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.91-5.21
52W High
+21.8%
52W Low
+204.5%
RSI
51
Rel Volume
4.91
Avg Volume
14.38M
Volume
70.67M
Perf Week
-2.72%
Perf Month
29.85%
Perf Quarter
37.78%
Perf Half Y
36.24%
-
-
-
-
Beta
0.385
-
-
Volatility
0.17%, 0.99%
Prev Close
0%
Price
6.09
Change
-5.58%

002688.SZ Financial Performance

002688.SZ Dividend History

002688.SZ Frequently Asked Questions

What is Jinhe Biotechnology CO., LTD. stock symbol ?

Jinhe Biotechnology CO., LTD. is a CN stock and trading under the symbol 002688.SZ

What is Jinhe Biotechnology CO., LTD. stock quote today ?

Jinhe Biotechnology CO., LTD. stock price is $6.09 today.

Is Jinhe Biotechnology CO., LTD. stock public?

Yes, Jinhe Biotechnology CO., LTD. is a publicly traded company.

Something similar

Top by Market Cap
VTI
BRK-A
LLY.DE
VFINX
TL0.DE
Top Correlated ETFs
VXX
VIXY
YXI
SCO
BIS
Top Correlated Stocks
TWOH
600598.SS
600371.SS
002900.SZ
300761.SZ
Similar Market Cap
COUR
ESYJY
KMT
MOR
PXF

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 14.38M
  • Market Capitalization 2.96B
  • Employee 2.29K
  • CEO Mr. Changxian Xie
  • Headquarters Dalian,CN
  • IPO Date 2012-07-13
  • Website https://www.jinhe.com.cn

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera. It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. The company was founded in 1990 and is based in Dalian, China.